soul trial oral semaglutide cardiovascular outcomes results 2024 nejm PDF) and in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the Randomized Oral Semaglutide and Cardiovascular Outcomes

This expanded receptor activation explains the distinct clinical effects observed with retatrutide

Evidence-backed comparison of psyllium vs GLP-1s, trial results, and practical guidance to help you choose the right path

GLP-1 receptor agonists show potential anti-inflammatory mechanisms, but evidence for rheumatoid arthritis benefit remains limited

Originally developed for diabetes and weight management, GLP-1 medications, including semaglutide and tirzepatide, now intersect with the care of patients with inflammatory arthritis, osteoarthritis and systemic []

HOW TO TAKE: Take one capsule with a meal for fast-acting bloating support anytime of the day